Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature.

Abstract excerpt

Previously an increased frequency of KIT aberrations in mucosal melanomas was reported, whereas c-KIT in most types of cutaneous melanomas does not appear to be of pathogenetic importance. Imatinib has become the standard of care in other cancers with KIT mutations such as gastrointestinal stromal tumors. Recently 12 cases of metastatic melanoma and KIT-activating mutations have been published to be successfully...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anus Neoplasms
• Share to Benzamides